Phacilitate Leaders World

Phacilitate:Exchange

Phacilitate:Exchange

WHAT IS PHACILITATE:EXCHANGE?

A SMALL INDUSTRY GROWING DRAMATICALLY...

One of Aristotle’s most famous musings has stood the test of time; the whole is indeed greater than the sum of its parts.

This profound statement is never truer than when applied to advanced therapies.

Ours is one of the fastest growing and most disruptive global industries and is set to change and inspire the world. In order to develop and deliver new, life-changing therapies to patients we must collaborate, exchange ideas and share knowledge. I’d like to introduce you to the latest knowledge sharing platform…

 

This video showcases how important collaboration is to our community and what Phacilitate:Exchange means to them.

 

In reality, this is the largest online advanced therapies community with contributors and members from all corners of the globe and every part of the industry’s ecosystem. You may have been attending Phacilitate events for 15 years but now you have a platform to access quality, original content year-round.

subscribe


This is a resource for the advanced therapies community, by the advanced therapies community.  Find out where the industry is going next…

Subscribe to phacilitate

Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
    EUFETS GmbH
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
    Dendreon
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman
    GSK